Oncology Institute provides investor presentation with no specific new financial disclosures

Oncology Institute, Inc.

Investor presentation furnished under Regulation FD on November 14, 2025.
Presentation content not disclosed in filing; exhibit text appears corrupted or incomplete.
No accompanying earnings release, guidance change, or material event noted.
Company common stock (TOI) and warrants (TOIIW) listed on Nasdaq.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.